Tomosynthesis Mammographic Imaging Screening Trial/EA1151 Study

Do you want to help doctors develop ways to personalize breast cancer screening for women in the future?  If so, will you consider participating in a breast cancer screening study?

We are currently recruiting women to Tomosynthesis Mammographic Imaging Screening Trial (TMIST), a clinical trial that will help us develop strategies that tailor breast cancer screening to the risks of individual women.

If you decide to participate, you will be involved in this research study for up to 8 years starting with your first mammogram.  During this time:
– You will be randomized (assigned by a computer) to get either a 3D or 2D mammograms for the first 5 years of the study
– Most women in the trial will be screened annually, but postmenopausal women with no high-risk factors will be screened every two years
– We will follow your breast cancer status for up to 8 years in total, including the screening years, by reviewing your medical records and, if needed, contacting you by phone

To participate or learn more about this study, contact Cheyenne Tashombe at (808) 564-5805 or email at This email address is being protected from spambots. You need JavaScript enabled to view it.

ELIGIBILITY:
You must be
• 45-74 years of age
• Scheduled for a screening mammogram

and

You must not
• Be pregnant, intend to be pregnant, or lactating
• Have symptoms of breast disease
• Have had screening mammogram in the last 11 months
• Have a history of breast cancer
• Currently have breast implants or other breast enhancements